Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPRML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBBP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHRS4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNF130 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POGLUT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM170B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM97 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060817 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on